Mumbai-based Unichem Laboratories Ltd has received an Order-in-Appeal from the Commissioner (Appeals), Thane, involving a total ₹93.66 crore comprising an ₹87.07 crore penalty and ₹6.59 crore interest liability. According to reports from CNBC TV18, the order was received on September 18, 2026, after 2 pm. The case relates to alleged delayed payment of tax liability for supplies after the time of supply, in contravention of Section 13 of the CGST Act, 2017 and Rule 47 of the CGST Rules, 2017, resulting in the interest liability.
As reported by CNBC TV18, Unichem Laboratories stated there will be no material impact on its financial, operational or other activities. The penalty amount of ₹87 crore is under Section 74(1) and Section 122(2)(b) of the Central Goods and Services Tax (CGST) Act, 2017, while the interest liability of ₹6.58 crore relates to the corresponding section of the Maharashtra Goods and Services Tax Act, 2017. The company, based on legal advice, will take appropriate steps, including filing an appeal against the order within the prescribed timelines.
According to latest financial data, Unichem Laboratories reported total income of ₹648.23 crore for the quarter ending June 2026, representing an 8.29% growth compared to the previous quarter. The company achieved a profit after tax of ₹41.47 crore with a net profit margin of 6.40%, showing significant improvement from the ₹10.91 crore PAT recorded in March 2026. The company's EBIT margin stood at 8.58% for the quarter, demonstrating strong operational efficiency.
According to CNBC TV18, in February, Unichem Laboratories reported that the US Food and Drug Administration (USFDA) conducted an inspection at its Kolhapur active pharmaceutical ingredients (API) manufacturing facility. The inspection, carried out between January 27 and February 2, was closed with five observations. The company clarified that all observations relate to procedural aspects and are not linked to data integrity concerns. In an exchange filing, Unichem said it will submit its response to the USFDA within the stipulated 15-day timeframe.
As reported by CNBC TV18, on Friday (September 18), shares of Unichem Laboratories Ltd ended at ₹545.70, up by ₹1.35 from the previous close of ₹538.45, representing a 1.35% gain. The positive market response occurred after the GST order announcement, indicating investor confidence in the company's ability to manage regulatory challenges and legal proceedings. The stock has traded in a 52-week range of ₹278.20 to ₹687.20, with a current market capitalization of ₹3,842.04 crore.
